Thomas M. Wisniewski, MD
In this video interview, Thomas M. Wisniewski, MD, director of the Alzheimer's Disease Research Center and the Center for Cognitive Neurology at NYU Langone, discusses:
- how new targeting agents, approaches to modulate neuroinflammation and other interventions are making this “an exciting time in Alzheimer’s disease research”;
- whether positive data on medications targeting amyloid beta “will translate clear, clinical benefits” in ongoing trials;
- lifestyle modifications and medical interventions that can help reduce the risk for developing dementia and slow disease progression;
- the importance of supporting caregivers and providing them services; and
- making primary care physicians and geriatricians aware of how critical early diagnoses and interventions are.
Read more about